Latest Empire Genomics LLC Stories

BUFFALO, N.Y., Nov. 29, 2012 /PRNewswire/ -- Empire Genomics announced today it has acquired an exclusive license for patent pending novel genomic biomarkers from Emory University for use in developing a molecular diagnostic test that could help satisfy a large unmet medical need in determining ideal therapeutic treatment for multiple myeloma patients. Recent data point to certain genetic biomarkers that may identify which patients would benefit from receiving treatment with the...